The significance of Pin1 in the development of Alzheimer's disease - PubMed (original) (raw)
The significance of Pin1 in the development of Alzheimer's disease
Suqing Wang et al. J Alzheimers Dis. 2007 Mar.
Abstract
Pin1 protein, a peptidyl-prolyl cis-trans isomerase plays an important regulatory role in neuronal function. Recent studies indicate that Pin1 may promote the dephosphorylation of tau and restore its ability to bind to and polymerize microtubles. Previous studies on postmortem human brains showed that Pin1 is down-regulated in advanced Alzheimer's disease (AD) brains compared to age-matched non-demented controls. Because AD is a slowly progressive disease with a preclinical period that can last years, the abundance and regulatory function of Pin1 may vary on the course of the disease. In order to evaluate the potential contribution of Pin1 to AD pathogenesis, levels of mRNA, protein and isomerase activity of Pin1 and phosphorylated tau from postmortem brains of 10 persons with mild-cognitive impairment (MCI), 10 with AD and 10 age-matched no cognitive impairment (NCI) were measured. The relationship between Pin1 and phosphorylated tau as well as clinical and cognitive data were analyzed. The results indicated that Pin1 activity in MCI and AD were significantly higher than in NCI. Phosphorylated tau in MCI and AD was also higher than in NCI group. The positive correlation trend in MCI and the robust correlation in AD between Pin1 activity and phosphorylated tau implies that increasing phosphorylated tau during AD pathogenesis may induce the compensatory activation/up-regulation of Pin1, while the inverse correlation between Pin1 activity and phosphorylated tau in NCI group implies that decreased Pin1 may play a role in the initial accumulation of phosphorylated tau in AD pathogenesis.
Similar articles
- DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
Poli M, Gatta LB, Dominici R, Lovati C, Mariani C, Albertini A, Finazzi D. Poli M, et al. Neurosci Lett. 2005 Dec 2;389(2):66-70. doi: 10.1016/j.neulet.2005.07.027. Neurosci Lett. 2005. PMID: 16095818 - Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
Ueberham U, Rohn S, Ueberham E, Wodischeck S, Hilbrich I, Holzer M, Brückner MK, Gruschka H, Arendt T. Ueberham U, et al. Neuropathol Appl Neurobiol. 2014 Dec;40(7):815-32. doi: 10.1111/nan.12163. Neuropathol Appl Neurobiol. 2014. PMID: 24964035 - Pin1: a new outlook in Alzheimer's disease.
Lonati E, Masserini M, Bulbarelli A. Lonati E, et al. Curr Alzheimer Res. 2011 Sep;8(6):615-22. doi: 10.2174/156720511796717140. Curr Alzheimer Res. 2011. PMID: 21605045 Review. - Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Ramakrishnan P, Dickson DW, Davies P. Ramakrishnan P, et al. Neurobiol Dis. 2003 Nov;14(2):251-64. doi: 10.1016/s0969-9961(03)00109-8. Neurobiol Dis. 2003. PMID: 14572447 - Pin1 in Alzheimer's disease.
Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R. Butterfield DA, et al. J Neurochem. 2006 Sep;98(6):1697-706. doi: 10.1111/j.1471-4159.2006.03995.x. J Neurochem. 2006. PMID: 16945100 Review.
Cited by
- Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
Bianchi M, Manco M. Bianchi M, et al. Int J Mol Sci. 2018 Aug 8;19(8):2319. doi: 10.3390/ijms19082319. Int J Mol Sci. 2018. PMID: 30096758 Free PMC article. Review. - Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease.
Huang JY, Hafez DM, James BD, Bennett DA, Marr RA. Huang JY, et al. J Alzheimers Dis. 2012;28(2):433-41. doi: 10.3233/JAD-2011-111307. J Alzheimers Dis. 2012. PMID: 22008264 Free PMC article. - A common biological mechanism in cancer and Alzheimer's disease?
Behrens MI, Lendon C, Roe CM. Behrens MI, et al. Curr Alzheimer Res. 2009 Jun;6(3):196-204. doi: 10.2174/156720509788486608. Curr Alzheimer Res. 2009. PMID: 19519301 Free PMC article. Review. - Molecular crosstalk between cancer and neurodegenerative diseases.
Seo J, Park M. Seo J, et al. Cell Mol Life Sci. 2020 Jul;77(14):2659-2680. doi: 10.1007/s00018-019-03428-3. Epub 2019 Dec 28. Cell Mol Life Sci. 2020. PMID: 31884567 Free PMC article. Review. - Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
Yarchoan M, James BD, Shah RC, Arvanitakis Z, Wilson RS, Schneider J, Bennett DA, Arnold SE. Yarchoan M, et al. J Alzheimers Dis. 2017;56(2):699-706. doi: 10.3233/JAD-160977. J Alzheimers Dis. 2017. PMID: 28035936 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 5R01AG010675/AG/NIA NIH HHS/United States
- P30AG10161/AG/NIA NIH HHS/United States
- P50HD03352/HD/NICHD NIH HHS/United States
- R01AG15819/AG/NIA NIH HHS/United States
- R03AG025722/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous